Featured Content

  1. Infusion icon


    Ocrelizumab is an experimental drug treatment being tested in relapsing remitting MS and primary progressive multiple sclerosis. 

  2. Got a question about MS?

    MS Trust is accredited by the Information Standard so you can trust us for reliable up to date information.

  1. Read about Ocrelizumab
  2. Help fund MS nurses
  3. Get in touch

Your stories

There are over 100,000 people living with MS in the UK today. But MS affects everyone differently. Find out more about how some people have adapted to living life with MS.

New year, new challenge

See new places, make new friends, push yourself out of your comfort zone and help people with MS.